Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro

Nonggao He, Sharad S. Singhal, Sanjay Awasthi, Tiejun Zhao, Paul J. Boor

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Allylamine (AA) is a cardiovascular toxin that causes lesions resembling atherosclerosis in several mammalian species. AA's toxic effects are thought to be exerted through its conversion to acrolein (AC), a potent electrophilic alkylating agent and atherogen. Semicarbazide sensitive amine oxidase (SSAO) catalyzes the oxidation of AA to AC. Glutathione S-transferases (GST) can catalyze the first step of detoxification of AC to mercapturic acid. Our previous studies suggest that the isozyme rGST8-8 is a principal defense against electrophilic stress exerted by α,β-unsaturated carbonyls such as AC. In the present studies, we use cultured rat vascular smooth muscle cells (VSMC) to examine the relative roles of SSAO and rGST8-8 in the cytotoxic effects of the atherogens, AA and AC. Exposure derived AA-resistant cells (VSMC-AA) were 3.5-fold more resistant to AA when compared to VSMC and 1.8- fold more resistant to acrolein. SSAO activity was 2-fold higher in VSMC-AA than in VSMC. Consistent with the role of SSAO in biotransformation of AA, the SSAO inhibitor semicarbazide (SC; 100 μM) provided nearly complete protection from AA to both VSMC-AA and VSMC. As expected, SC did not affect the cytotoxicity of AC. Pretreatment with 100 μM sulfasalazine (SS), a GST inhibitor, potentiated AA and AC toxicity in both VSMC-AA and VSMC, indicating a protective role of GST. Catalytic efficiency (K(cat)/K(m)) of GSTs was higher toward 4-hydroxynonenal (4-HNE) (0.65 mM-1 s-1) than toward 1-chloro-2,4-dinitrobenzene (CDNB) (0.14 mM-1 s-1) for VSMC. In VSMC-AA, K(cat)/K(m) was increased 4.1-fold toward CDNB (0.58 mM-1 s-1) and 6-fold toward 4HNE (3.9 mM-1 s-1) when compared to VSMC, indicating a preferential increase in VSMC-AA of GST isozymes which utilize α,β- unsaturated carbonyls. Western blots confirmed induction of rGST8-8 in VSMC- AA. Expression of recombinant mGSTA4 (the mouse homolog of rGST8-8) in VSMC caused a 1.6-fold increase in resistance to AA and AC. This resistance was fully reversed by 50 μM SS. Our results demonstrate that GSTs are an important defense against electrophilic atherogens and that isozymes with high activity toward α,β-unsaturated carbonyls are particularly important in the vascular wall.

Original languageEnglish (US)
Pages (from-to)177-185
Number of pages9
JournalToxicology and Applied Pharmacology
Volume158
Issue number2
DOIs
StatePublished - Jul 15 1999

Fingerprint

Allylamine
Glutathione Transferase
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Acrolein
Cells
Amine Oxidase (Copper-Containing)
Isoenzymes
Sulfasalazine
In Vitro Techniques
Cats
Dinitrochlorobenzene
Detoxification

Keywords

  • Acrolein
  • Allylamine
  • Allylamine-resistant cell line
  • Glutathione S-transferases
  • Rat GST8-8
  • Semicarbazide-sensitive amine oxidase
  • Vascular smooth muscle cells

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro. / He, Nonggao; Singhal, Sharad S.; Awasthi, Sanjay; Zhao, Tiejun; Boor, Paul J.

In: Toxicology and Applied Pharmacology, Vol. 158, No. 2, 15.07.1999, p. 177-185.

Research output: Contribution to journalArticle

He, Nonggao ; Singhal, Sharad S. ; Awasthi, Sanjay ; Zhao, Tiejun ; Boor, Paul J. / Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro. In: Toxicology and Applied Pharmacology. 1999 ; Vol. 158, No. 2. pp. 177-185.
@article{c32c8367c2644d47809199a6de26283e,
title = "Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro",
abstract = "Allylamine (AA) is a cardiovascular toxin that causes lesions resembling atherosclerosis in several mammalian species. AA's toxic effects are thought to be exerted through its conversion to acrolein (AC), a potent electrophilic alkylating agent and atherogen. Semicarbazide sensitive amine oxidase (SSAO) catalyzes the oxidation of AA to AC. Glutathione S-transferases (GST) can catalyze the first step of detoxification of AC to mercapturic acid. Our previous studies suggest that the isozyme rGST8-8 is a principal defense against electrophilic stress exerted by α,β-unsaturated carbonyls such as AC. In the present studies, we use cultured rat vascular smooth muscle cells (VSMC) to examine the relative roles of SSAO and rGST8-8 in the cytotoxic effects of the atherogens, AA and AC. Exposure derived AA-resistant cells (VSMC-AA) were 3.5-fold more resistant to AA when compared to VSMC and 1.8- fold more resistant to acrolein. SSAO activity was 2-fold higher in VSMC-AA than in VSMC. Consistent with the role of SSAO in biotransformation of AA, the SSAO inhibitor semicarbazide (SC; 100 μM) provided nearly complete protection from AA to both VSMC-AA and VSMC. As expected, SC did not affect the cytotoxicity of AC. Pretreatment with 100 μM sulfasalazine (SS), a GST inhibitor, potentiated AA and AC toxicity in both VSMC-AA and VSMC, indicating a protective role of GST. Catalytic efficiency (K(cat)/K(m)) of GSTs was higher toward 4-hydroxynonenal (4-HNE) (0.65 mM-1 s-1) than toward 1-chloro-2,4-dinitrobenzene (CDNB) (0.14 mM-1 s-1) for VSMC. In VSMC-AA, K(cat)/K(m) was increased 4.1-fold toward CDNB (0.58 mM-1 s-1) and 6-fold toward 4HNE (3.9 mM-1 s-1) when compared to VSMC, indicating a preferential increase in VSMC-AA of GST isozymes which utilize α,β- unsaturated carbonyls. Western blots confirmed induction of rGST8-8 in VSMC- AA. Expression of recombinant mGSTA4 (the mouse homolog of rGST8-8) in VSMC caused a 1.6-fold increase in resistance to AA and AC. This resistance was fully reversed by 50 μM SS. Our results demonstrate that GSTs are an important defense against electrophilic atherogens and that isozymes with high activity toward α,β-unsaturated carbonyls are particularly important in the vascular wall.",
keywords = "Acrolein, Allylamine, Allylamine-resistant cell line, Glutathione S-transferases, Rat GST8-8, Semicarbazide-sensitive amine oxidase, Vascular smooth muscle cells",
author = "Nonggao He and Singhal, {Sharad S.} and Sanjay Awasthi and Tiejun Zhao and Boor, {Paul J.}",
year = "1999",
month = "7",
day = "15",
doi = "10.1006/taap.1999.8700",
language = "English (US)",
volume = "158",
pages = "177--185",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro

AU - He, Nonggao

AU - Singhal, Sharad S.

AU - Awasthi, Sanjay

AU - Zhao, Tiejun

AU - Boor, Paul J.

PY - 1999/7/15

Y1 - 1999/7/15

N2 - Allylamine (AA) is a cardiovascular toxin that causes lesions resembling atherosclerosis in several mammalian species. AA's toxic effects are thought to be exerted through its conversion to acrolein (AC), a potent electrophilic alkylating agent and atherogen. Semicarbazide sensitive amine oxidase (SSAO) catalyzes the oxidation of AA to AC. Glutathione S-transferases (GST) can catalyze the first step of detoxification of AC to mercapturic acid. Our previous studies suggest that the isozyme rGST8-8 is a principal defense against electrophilic stress exerted by α,β-unsaturated carbonyls such as AC. In the present studies, we use cultured rat vascular smooth muscle cells (VSMC) to examine the relative roles of SSAO and rGST8-8 in the cytotoxic effects of the atherogens, AA and AC. Exposure derived AA-resistant cells (VSMC-AA) were 3.5-fold more resistant to AA when compared to VSMC and 1.8- fold more resistant to acrolein. SSAO activity was 2-fold higher in VSMC-AA than in VSMC. Consistent with the role of SSAO in biotransformation of AA, the SSAO inhibitor semicarbazide (SC; 100 μM) provided nearly complete protection from AA to both VSMC-AA and VSMC. As expected, SC did not affect the cytotoxicity of AC. Pretreatment with 100 μM sulfasalazine (SS), a GST inhibitor, potentiated AA and AC toxicity in both VSMC-AA and VSMC, indicating a protective role of GST. Catalytic efficiency (K(cat)/K(m)) of GSTs was higher toward 4-hydroxynonenal (4-HNE) (0.65 mM-1 s-1) than toward 1-chloro-2,4-dinitrobenzene (CDNB) (0.14 mM-1 s-1) for VSMC. In VSMC-AA, K(cat)/K(m) was increased 4.1-fold toward CDNB (0.58 mM-1 s-1) and 6-fold toward 4HNE (3.9 mM-1 s-1) when compared to VSMC, indicating a preferential increase in VSMC-AA of GST isozymes which utilize α,β- unsaturated carbonyls. Western blots confirmed induction of rGST8-8 in VSMC- AA. Expression of recombinant mGSTA4 (the mouse homolog of rGST8-8) in VSMC caused a 1.6-fold increase in resistance to AA and AC. This resistance was fully reversed by 50 μM SS. Our results demonstrate that GSTs are an important defense against electrophilic atherogens and that isozymes with high activity toward α,β-unsaturated carbonyls are particularly important in the vascular wall.

AB - Allylamine (AA) is a cardiovascular toxin that causes lesions resembling atherosclerosis in several mammalian species. AA's toxic effects are thought to be exerted through its conversion to acrolein (AC), a potent electrophilic alkylating agent and atherogen. Semicarbazide sensitive amine oxidase (SSAO) catalyzes the oxidation of AA to AC. Glutathione S-transferases (GST) can catalyze the first step of detoxification of AC to mercapturic acid. Our previous studies suggest that the isozyme rGST8-8 is a principal defense against electrophilic stress exerted by α,β-unsaturated carbonyls such as AC. In the present studies, we use cultured rat vascular smooth muscle cells (VSMC) to examine the relative roles of SSAO and rGST8-8 in the cytotoxic effects of the atherogens, AA and AC. Exposure derived AA-resistant cells (VSMC-AA) were 3.5-fold more resistant to AA when compared to VSMC and 1.8- fold more resistant to acrolein. SSAO activity was 2-fold higher in VSMC-AA than in VSMC. Consistent with the role of SSAO in biotransformation of AA, the SSAO inhibitor semicarbazide (SC; 100 μM) provided nearly complete protection from AA to both VSMC-AA and VSMC. As expected, SC did not affect the cytotoxicity of AC. Pretreatment with 100 μM sulfasalazine (SS), a GST inhibitor, potentiated AA and AC toxicity in both VSMC-AA and VSMC, indicating a protective role of GST. Catalytic efficiency (K(cat)/K(m)) of GSTs was higher toward 4-hydroxynonenal (4-HNE) (0.65 mM-1 s-1) than toward 1-chloro-2,4-dinitrobenzene (CDNB) (0.14 mM-1 s-1) for VSMC. In VSMC-AA, K(cat)/K(m) was increased 4.1-fold toward CDNB (0.58 mM-1 s-1) and 6-fold toward 4HNE (3.9 mM-1 s-1) when compared to VSMC, indicating a preferential increase in VSMC-AA of GST isozymes which utilize α,β- unsaturated carbonyls. Western blots confirmed induction of rGST8-8 in VSMC- AA. Expression of recombinant mGSTA4 (the mouse homolog of rGST8-8) in VSMC caused a 1.6-fold increase in resistance to AA and AC. This resistance was fully reversed by 50 μM SS. Our results demonstrate that GSTs are an important defense against electrophilic atherogens and that isozymes with high activity toward α,β-unsaturated carbonyls are particularly important in the vascular wall.

KW - Acrolein

KW - Allylamine

KW - Allylamine-resistant cell line

KW - Glutathione S-transferases

KW - Rat GST8-8

KW - Semicarbazide-sensitive amine oxidase

KW - Vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0033566203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033566203&partnerID=8YFLogxK

U2 - 10.1006/taap.1999.8700

DO - 10.1006/taap.1999.8700

M3 - Article

VL - 158

SP - 177

EP - 185

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -